Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-05-07 00:00:00 ET · period of report 2024-05-03 · accession 0001415889-24-012536 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-07 | 2024-05-03 | ELVN | Hohl Benjamin | CFO | S - Sale+OE | $22.50 | -1,000 | 0 | -100% | -$22.5K |
| D | 2024-05-07 | 2024-05-03 | ELVN | Hohl Benjamin | CFO | M - OptEx | $2.48 | +1,000 | 1,000 | New | +$2,480 |
| D | 2024-05-07 | 2024-05-03 | ELVN | Hohl Benjamin | CFO | M - OptEx | $0.00 | -1,000 | 221.1K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-03 | S | D | 1,000 | $22.50 | 0 | D | — | — | |
| 2 | Common | Common Stock | 2024-05-03 | M | A | 1,000 | $2.48 | 1,000 | D | — | — | |
| 3 | Derivative | Stock Option (right to buy) | 2024-05-03 | M | D | 1,000 | $0.00 | 221,120 | D | $2.48 · — to 2031-08-02 | 1,000 Common Stock | (F2) The option, originally for 262,120 shares, vested as to one-fourth of the shares on August 2, 2022, and the remainder of the shares vest in 36 equal monthly installments thereafter. |